The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Clinical Trial and Analysis Services Market Research Report 2024

Global Clinical Trial and Analysis Services Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1786925

No of Pages : 116

Synopsis
Global Clinical Trial and Analysis Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Clinical Trial and Analysis Services market research.
Key companies engaged in the Clinical Trial and Analysis Services industry include PCI Pharma Services, Quintiles, QPS, CDC Group, NextStage Clinical Research, SanaClis, Caidya, IQVIA and WuXi AppTec, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Clinical Trial and Analysis Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Clinical Trial and Analysis Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Clinical Trial and Analysis Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PCI Pharma Services
Quintiles
QPS
CDC Group
NextStage Clinical Research
SanaClis
Caidya
IQVIA
WuXi AppTec
CIRS
YIDU Technology
Precision Scientific
EPS TIGERMED (SUZHOU)CO..LTD
BOSTAL
JOINN
YUANBO
ZC-MED
George Clinical
ClinHope
PHARMARON
Taicheng Yaozhong
Thermo Fisher Scientific
Segment by Type
On-site Services
Off-site Services
Segment by Application
Hospital
Government & Regulatory Agencies
Pharmaceutical Company
Academic Centre
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Clinical Trial and Analysis Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial and Analysis Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 On-site Services
1.2.3 Off-site Services
1.3 Market by Application
1.3.1 Global Clinical Trial and Analysis Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Government & Regulatory Agencies
1.3.4 Pharmaceutical Company
1.3.5 Academic Centre
1.3.6 CRO
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial and Analysis Services Market Perspective (2018-2029)
2.2 Clinical Trial and Analysis Services Growth Trends by Region
2.2.1 Global Clinical Trial and Analysis Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial and Analysis Services Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trial and Analysis Services Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trial and Analysis Services Market Dynamics
2.3.1 Clinical Trial and Analysis Services Industry Trends
2.3.2 Clinical Trial and Analysis Services Market Drivers
2.3.3 Clinical Trial and Analysis Services Market Challenges
2.3.4 Clinical Trial and Analysis Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial and Analysis Services Players by Revenue
3.1.1 Global Top Clinical Trial and Analysis Services Players by Revenue (2018-2023)
3.1.2 Global Clinical Trial and Analysis Services Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trial and Analysis Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial and Analysis Services Revenue
3.4 Global Clinical Trial and Analysis Services Market Concentration Ratio
3.4.1 Global Clinical Trial and Analysis Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial and Analysis Services Revenue in 2022
3.5 Clinical Trial and Analysis Services Key Players Head office and Area Served
3.6 Key Players Clinical Trial and Analysis Services Product Solution and Service
3.7 Date of Enter into Clinical Trial and Analysis Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial and Analysis Services Breakdown Data by Type
4.1 Global Clinical Trial and Analysis Services Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trial and Analysis Services Forecasted Market Size by Type (2024-2029)
5 Clinical Trial and Analysis Services Breakdown Data by Application
5.1 Global Clinical Trial and Analysis Services Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trial and Analysis Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial and Analysis Services Market Size (2018-2029)
6.2 North America Clinical Trial and Analysis Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Clinical Trial and Analysis Services Market Size by Country (2018-2023)
6.4 North America Clinical Trial and Analysis Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial and Analysis Services Market Size (2018-2029)
7.2 Europe Clinical Trial and Analysis Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Clinical Trial and Analysis Services Market Size by Country (2018-2023)
7.4 Europe Clinical Trial and Analysis Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial and Analysis Services Market Size (2018-2029)
8.2 Asia-Pacific Clinical Trial and Analysis Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Clinical Trial and Analysis Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Trial and Analysis Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial and Analysis Services Market Size (2018-2029)
9.2 Latin America Clinical Trial and Analysis Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Clinical Trial and Analysis Services Market Size by Country (2018-2023)
9.4 Latin America Clinical Trial and Analysis Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial and Analysis Services Market Size (2018-2029)
10.2 Middle East & Africa Clinical Trial and Analysis Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Clinical Trial and Analysis Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Trial and Analysis Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PCI Pharma Services
11.1.1 PCI Pharma Services Company Detail
11.1.2 PCI Pharma Services Business Overview
11.1.3 PCI Pharma Services Clinical Trial and Analysis Services Introduction
11.1.4 PCI Pharma Services Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.1.5 PCI Pharma Services Recent Development
11.2 Quintiles
11.2.1 Quintiles Company Detail
11.2.2 Quintiles Business Overview
11.2.3 Quintiles Clinical Trial and Analysis Services Introduction
11.2.4 Quintiles Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.2.5 Quintiles Recent Development
11.3 QPS
11.3.1 QPS Company Detail
11.3.2 QPS Business Overview
11.3.3 QPS Clinical Trial and Analysis Services Introduction
11.3.4 QPS Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.3.5 QPS Recent Development
11.4 CDC Group
11.4.1 CDC Group Company Detail
11.4.2 CDC Group Business Overview
11.4.3 CDC Group Clinical Trial and Analysis Services Introduction
11.4.4 CDC Group Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.4.5 CDC Group Recent Development
11.5 NextStage Clinical Research
11.5.1 NextStage Clinical Research Company Detail
11.5.2 NextStage Clinical Research Business Overview
11.5.3 NextStage Clinical Research Clinical Trial and Analysis Services Introduction
11.5.4 NextStage Clinical Research Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.5.5 NextStage Clinical Research Recent Development
11.6 SanaClis
11.6.1 SanaClis Company Detail
11.6.2 SanaClis Business Overview
11.6.3 SanaClis Clinical Trial and Analysis Services Introduction
11.6.4 SanaClis Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.6.5 SanaClis Recent Development
11.7 Caidya
11.7.1 Caidya Company Detail
11.7.2 Caidya Business Overview
11.7.3 Caidya Clinical Trial and Analysis Services Introduction
11.7.4 Caidya Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.7.5 Caidya Recent Development
11.8 IQVIA
11.8.1 IQVIA Company Detail
11.8.2 IQVIA Business Overview
11.8.3 IQVIA Clinical Trial and Analysis Services Introduction
11.8.4 IQVIA Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.8.5 IQVIA Recent Development
11.9 WuXi AppTec
11.9.1 WuXi AppTec Company Detail
11.9.2 WuXi AppTec Business Overview
11.9.3 WuXi AppTec Clinical Trial and Analysis Services Introduction
11.9.4 WuXi AppTec Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.9.5 WuXi AppTec Recent Development
11.10 CIRS
11.10.1 CIRS Company Detail
11.10.2 CIRS Business Overview
11.10.3 CIRS Clinical Trial and Analysis Services Introduction
11.10.4 CIRS Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.10.5 CIRS Recent Development
11.11 YIDU Technology
11.11.1 YIDU Technology Company Detail
11.11.2 YIDU Technology Business Overview
11.11.3 YIDU Technology Clinical Trial and Analysis Services Introduction
11.11.4 YIDU Technology Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.11.5 YIDU Technology Recent Development
11.12 Precision Scientific
11.12.1 Precision Scientific Company Detail
11.12.2 Precision Scientific Business Overview
11.12.3 Precision Scientific Clinical Trial and Analysis Services Introduction
11.12.4 Precision Scientific Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.12.5 Precision Scientific Recent Development
11.13 EPS TIGERMED (SUZHOU)CO..LTD
11.13.1 EPS TIGERMED (SUZHOU)CO..LTD Company Detail
11.13.2 EPS TIGERMED (SUZHOU)CO..LTD Business Overview
11.13.3 EPS TIGERMED (SUZHOU)CO..LTD Clinical Trial and Analysis Services Introduction
11.13.4 EPS TIGERMED (SUZHOU)CO..LTD Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.13.5 EPS TIGERMED (SUZHOU)CO..LTD Recent Development
11.14 BOSTAL
11.14.1 BOSTAL Company Detail
11.14.2 BOSTAL Business Overview
11.14.3 BOSTAL Clinical Trial and Analysis Services Introduction
11.14.4 BOSTAL Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.14.5 BOSTAL Recent Development
11.15 JOINN
11.15.1 JOINN Company Detail
11.15.2 JOINN Business Overview
11.15.3 JOINN Clinical Trial and Analysis Services Introduction
11.15.4 JOINN Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.15.5 JOINN Recent Development
11.16 YUANBO
11.16.1 YUANBO Company Detail
11.16.2 YUANBO Business Overview
11.16.3 YUANBO Clinical Trial and Analysis Services Introduction
11.16.4 YUANBO Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.16.5 YUANBO Recent Development
11.17 ZC-MED
11.17.1 ZC-MED Company Detail
11.17.2 ZC-MED Business Overview
11.17.3 ZC-MED Clinical Trial and Analysis Services Introduction
11.17.4 ZC-MED Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.17.5 ZC-MED Recent Development
11.18 George Clinical
11.18.1 George Clinical Company Detail
11.18.2 George Clinical Business Overview
11.18.3 George Clinical Clinical Trial and Analysis Services Introduction
11.18.4 George Clinical Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.18.5 George Clinical Recent Development
11.19 ClinHope
11.19.1 ClinHope Company Detail
11.19.2 ClinHope Business Overview
11.19.3 ClinHope Clinical Trial and Analysis Services Introduction
11.19.4 ClinHope Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.19.5 ClinHope Recent Development
11.20 PHARMARON
11.20.1 PHARMARON Company Detail
11.20.2 PHARMARON Business Overview
11.20.3 PHARMARON Clinical Trial and Analysis Services Introduction
11.20.4 PHARMARON Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.20.5 PHARMARON Recent Development
11.21 Taicheng Yaozhong
11.21.1 Taicheng Yaozhong Company Detail
11.21.2 Taicheng Yaozhong Business Overview
11.21.3 Taicheng Yaozhong Clinical Trial and Analysis Services Introduction
11.21.4 Taicheng Yaozhong Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.21.5 Taicheng Yaozhong Recent Development
11.22 Thermo Fisher Scientific
11.22.1 Thermo Fisher Scientific Company Detail
11.22.2 Thermo Fisher Scientific Business Overview
11.22.3 Thermo Fisher Scientific Clinical Trial and Analysis Services Introduction
11.22.4 Thermo Fisher Scientific Revenue in Clinical Trial and Analysis Services Business (2018-2023)
11.22.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’